Pilocytic astrocytoma
Slow-growing, benign brain tumor most common in children.
Pilocytic astrocytoma is a slow-growing, benign brain tumor classified as WHO malignancy grade 1. It occurs most commonly in children and young adults within the first 20 years of life, typically arising in the cerebellum, near the brainstem, in the hypothalamic region, or the optic chiasm, though it may appear in any area where astrocytes are present. This tumor is the single most common childhood brain tumor, accounting for nearly 20% of brain tumors diagnosed in children aged 0–14 years, with a peak incidence between 5 and 14 years of age.
Quick Facts
- Field
- Neuro-oncology, neurosurgery
- Symptoms
- lack of appropriate weight gain/ weight loss / headaches / nausea / vomiting / irritability / torticollis / difficulty to coordinate movements
- Onset
- First 20 years of life
- Diagnosis
- MRI, CT scan
Facts from the source article.
Lore & Background
Pilocytic astrocytoma is often associated with the genetic condition neurofibromatosis type 1, and optic nerve gliomas are among the most frequently encountered tumors in patients with this disorder. However, the majority of pilocytic astrocytomas arise sporadically, with no evidence of a link to an underlying hereditary predisposition or lifestyle factor. They are associated with genetic alterations in the MAPK/ERK pathway, most frequently a characteristic KIAA1549–BRAF fusion gene.
Children affected by pilocytic astrocytoma may present with symptoms including failure to thrive, headache, nausea, vomiting, irritability, torticollis, difficulty coordinating movements, and visual complaints such as nystagmus. The most common symptoms are associated with increased intracranial pressure due to the size of the tumor mass. Diagnosis typically involves a clinical exam, neurological exam, ophthalmological exam, and imaging such as CT or MRI scans, often with contrast dye. A biopsy is usually required to confirm the tumor type.
Under the microscope, pilocytic astrocytomas are composed of bipolar cells with long 'hair-like' GFAP-positive processes. They often contain Rosenthal fibers, eosinophilic granular bodies, and microcysts. The most common treatment is surgical removal; complete resection generally allows functional survival for many years. If surgery is not possible, chemotherapy or radiation may be recommended, though side effects can be extensive and long term, particularly in pediatric patients.
Reader's Guide
Pilocytic astrocytoma is significant as the most common childhood brain tumor, representing about 20% of brain tumors in children aged 0–14 years. Its classification as WHO grade 1 reflects its typically benign, slow-growing nature, and complete surgical resection is usually curative with low recurrence risk. The tumor's association with the MAPK/ERK pathway, particularly the KIAA1549–BRAF fusion, has provided insight into its molecular pathogenesis. Its link to neurofibromatosis type 1 highlights the role of genetic predisposition in a subset of cases. The pilomyxoid astrocytoma variant may behave more aggressively, possibly due to younger age at presentation and midline location. Despite its generally favorable prognosis, treatment challenges arise when tumors are located in inaccessible areas, requiring careful monitoring or alternative therapies. The tumor's high incidence in children underscores the importance of pediatric neuro-oncology research and long-term follow-up for treatment side effects.
Did You Know?
- Pilocytic astrocytoma can be associated with the genetic condition neurofibromatosis type 1, especially optic nerve gliomas.
- The tumor's name comes from its microscopic appearance: bipolar cells with long 'hair-like' GFAP-positive processes.
More in Disorders causing seizures 1-24
Spotted an error? Know more?
Reader corrections go straight into our review queue. Suggest an edit · How this site is sourced